Spyre Therapeutics
SYRE
SYRE
71 hedge funds and large institutions have $159M invested in Spyre Therapeutics in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 60 → 71 (+11)
0% more ownership
Funds ownership: 2.74% → 2.74% (+0%)
Holders
71
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$4.03M | |
| 2 | +$3.11M | |
| 3 | +$3.03M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.02M |
| 5 |
ACM
Aisling Capital Management
New York
|
+$2.84M |
Top Sellers
| 1 | -$4.63M | |
| 2 | -$276K | |
| 3 | -$167K | |
| 4 |
Morgan Stanley
New York
|
-$147K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$116K |